Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thrombosis 3Pulmonary Embolism 3Neoplasms 3Venous Thromboembolism 2Thrombosis 1Myeloproliferative Disorders 1

Interventions

Dalteparin 9apixaban 7Enoxaparin 7Tinzaparin 5edoxaban 4Rivaroxaban 4Heparin, Low-Molecular-Weight 3Dabigatran 3Warfarin 2Fondaparinux 2reviparin 1myotubularin 1certoparin 1bemiparin 1atezolizumab 1acarboxyprothrombin 1Ultrasonography, Doppler, Duplex 1Rosuvastatin Calcium 1Phenprocoumon 1Nadroparin 1Models, Biological 1Medication Therapy Management 1Laparoscopy 1Intermittent Pneumatic Compression Devices 1Imaging, Three-Dimensional 1Hospitals 1Heparin 1Fluorodeoxyglucose F18 1Educational Status 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Venous Thrombosis × Dabigatran × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01999179 2022-05-18

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Medical College of Wisconsin

Phase NA Completed
27 enrolled 8 charts

Neoplasms, Venous Thrombosis

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡